Tag: TVT 2022

TVT 2022: DAPT after Watchman FLX LAAO is comparable to currently approved regimens

Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO) using the Watchman...

TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device

Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston Scientific) device ...

TVT 2022: EXPAND registry shows benefit of MitraClip in patients outside of COAPT trial criteria

Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip treatment in secondar...

TVT 2022: New data “debunk idea that patients with pacemakers may not be eligible for TEER”

Data from the first report on patients with a pacemaker lead across the tricuspid valve have sho...